Cargando…
De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low. Herein, we report the case of a 42-year-old woman with a giant prolactinoma who developed a psychiatric disorder after 1 day of cabergoline the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338660/ https://www.ncbi.nlm.nih.gov/pubmed/37457316 http://dx.doi.org/10.1177/11795476231186062 |